Meredith S. Manning
Corporate Officer/Principal chez SOLENO THERAPEUTICS, INC.
Profil
Meredith S.
Manning is currently the Chief Commercial Officer at Soleno Therapeutics, Inc. She previously worked as the Vice President-Global Hemophilia Marketing at Baxter International, Inc. from 2013 to 2015.
She was also the President-Americas at PharmaEssentia Corp.
and the Chief Commercial Officer at resTORbio, Inc. from 2018 to 2019.
Ms. Manning received her undergraduate degree from The Colorado College and her MBA from The University of Chicago Booth School of Business.
Postes actifs de Meredith S. Manning
| Sociétés | Poste | Début |
|---|---|---|
| SOLENO THERAPEUTICS, INC. | Corporate Officer/Principal | 24/01/2024 |
Anciens postes connus de Meredith S. Manning
| Sociétés | Poste | Fin |
|---|---|---|
| ADICET BIO, INC. | Corporate Officer/Principal | 06/12/2019 |
| BAXTER INTERNATIONAL INC. | Sales & Marketing | 01/07/2015 |
| PHARMAESSENTIA CORPORATION | Corporate Officer/Principal | - |
Formation de Meredith S. Manning
| The Colorado College | Undergraduate Degree |
| The University of Chicago Booth School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| BAXTER INTERNATIONAL INC. | Health Technology |
| SOLENO THERAPEUTICS, INC. | Health Technology |
| PHARMAESSENTIA CORPORATION | Health Technology |
| Entreprise privées | 1 |
|---|---|
resTORbio, Inc.
 resTORbio, Inc. BiotechnologyHealth Technology resTORbio, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the development and commercialization of medicines for aging-related diseases and conditions. It offers an immunotherapy under the TORC1 program. The company was founded by Chen Schor and Joan Mannick on July 5, 2016 and is headquartered in Boston, MA. | Health Technology |
